Invacare Vergangene Ertragsentwicklung

Vergangenheit Kriterienprüfungen 0/6

InvacareDie Gewinne des Unternehmens sind mit einer durchschnittlichen jährlichen Rate von -2.6% zurückgegangen, während in der Branche Medical Equipment die Gewinne wachsen. Die Umsätze sind rückläufig mit einer durchschnittlichen Rate von 4.5% pro Jahr.

Wichtige Informationen

-2.6%

Wachstumsrate der Gewinne

-0.2%

EPS-Wachstumsrate

Medical Equipment Wachstum der Industrie	8.9%
Wachstumsrate der Einnahmen	-4.5%
Eigenkapitalrendite	-124.6%
Netto-Marge	-13.6%
Letzte Ertragsaktualisierung	31 Dec 2022

Jüngste Aktualisierungen vergangener Leistungen

Recent updates

Increases to CEO Compensation Might Be Put On Hold For Now at Invacare Corporation (NYSE:IVC)

May 14

Invacare EPS misses by $0.02, misses on revenue

May 05

Returns On Capital Are Showing Encouraging Signs At Invacare (NYSE:IVC)

May 03

Invacare Corporation's (NYSE:IVC) Path To Profitability

Mar 03

Invacare (NYSE:IVC) Has A Somewhat Strained Balance Sheet

Feb 05

What Can The Trends At Invacare (NYSE:IVC) Tell Us About Their Returns?

Jan 10

Invacare's(NYSE:IVC) Share Price Is Down 48% Over The Past Five Years.

Dec 14

Invacare Corporation's (NYSE:IVC) Shift From Loss To Profit

Nov 23

Invacare Corporation 2020 Q3 - Results - Earnings Call Presentation

Oct 30

Aufschlüsselung der Einnahmen und Ausgaben

Wie Invacare Geld verdient und ausgibt. Basierend auf den neuesten gemeldeten Einnahmen der letzten zwölf Monate.

Gewinn- und Umsatzhistorie

OTCPK:IVCR.Q Einnahmen, Ausgaben und Erträge (USD Millions)
Datum	Einnahmen	Umsatz	Allgemeine und Verwaltungskosten
31 Dec 22	742	-101	228
30 Sep 22	787	-79	225
30 Jun 22	840	-67	223
31 Mar 22	877	-56	232
31 Dec 21	872	-46	231
30 Sep 21	870	-53	241
30 Jun 21	858	-37	240
31 Mar 21	828	-43	234
31 Dec 20	851	-28	237
30 Sep 20	860	-42	236
30 Jun 20	883	-43	246
31 Mar 20	923	-39	256
31 Dec 19	928	-53	260
30 Sep 19	940	-36	264
30 Jun 19	948	-40	270
31 Mar 19	959	-44	276
31 Dec 18	972	-44	282
30 Sep 18	978	-60	288
30 Jun 18	984	-67	294
31 Mar 18	972	-74	295
31 Dec 17	966	-77	297
30 Sep 17	963	-77	299
30 Jun 17	980	-63	301
31 Mar 17	1,022	-51	304
31 Dec 16	1,047	-43	304
30 Sep 16	1,084	-28	303
30 Jun 16	1,100	-31	303

Qualität der Erträge: IVCR.Q ist derzeit unrentabel.

Wachsende Gewinnspanne: IVCR.Q ist derzeit unrentabel.

Analyse von freiem Cashflow und Gewinn

Analyse des Gewinnwachstums in der Vergangenheit

Ergebnisentwicklung: IVCR.Q ist unrentabel, und die Verluste haben in den letzten 5 Jahren mit einer Rate von 2.6% pro Jahr zugenommen.

Beschleunigtes Wachstum: Das Gewinnwachstum des letzten Jahres kann nicht mit dem 5-Jahres-Durchschnitt von IVCR.Q verglichen werden, da das Unternehmen derzeit nicht profitabel ist.

Erträge im Vergleich zur Industrie: IVCR.Q ist unrentabel, was einen Vergleich des Gewinnwachstums des letzten Jahres mit der Branche Medical Equipment (2.3%) erschwert.

Eigenkapitalrendite

Hohe Eigenkapitalrendite: IVCR.Q hat eine negative Eigenkapitalrendite (-124.64%), da es derzeit unrentabel ist.

Invacare Vergangene Ertragsentwicklung

Vergangenheit Kriterienprüfungen 0/6

Wichtige Informationen

Jüngste Aktualisierungen vergangener Leistungen

Third quarter 2022 earnings: EPS and revenues miss analyst expectations

Invacare Corporation to Report Q3, 2022 Results on Nov 07, 2022

Second quarter 2022 earnings: EPS and revenues miss analyst expectations

Invacare Corporation to Report Q2, 2022 Results on Aug 08, 2022

First quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Invacare Corporation to Report Q1, 2022 Results on May 09, 2022

Recent updates

Invacare Corporation announced delayed 10-Q filing

Silverback Asset Management Engages with Invacare Corporation

Invacare Corporation announced delayed annual 10-K filing

Invacare Corporation announced delayed 10-Q filing

Invacare Corporation Enters Settlement Agreement with Sunrise Medical (Us) Llc and Sunrise Medical Gmbh

Invacare Holdings Corporation Announces Executive Changes

Invacare Corporation(OTCPK:IVCR.Q) dropped from S&P TMI Index

NYSE to Suspend Trading Immediately in Invacare Corporation and Commence Delisting Proceedings

Invacare Corporation Filed for Bankruptcy

Invacare falls on bankruptcy filing

Invacare Corporation Filed for Bankruptcy

Invacare announces additional draw of $5.5M term loans

Invacare Corporation Appoints Geoffrey P. Purtill as President

Price target decreased to US$1.65

Invacare Corporation (NYSE:IVC) Analysts Just Slashed Next Year's Estimates

Third quarter 2022 earnings: EPS and revenues miss analyst expectations

Invacare GAAP EPS of -$0.92, revenue of $170.4M

Invacare Corporation to Report Q3, 2022 Results on Nov 07, 2022

Invacare Corporation Receives Notice of Noncompliance with NYSE Trading Share Price Listing Rule

Invacare receives non-compliance letter from NYSE

Invacare Corporation Announces Executive Changes

Invacare names Geoffrey Purtill as interim president and executive chief

Invacare Corporation Announces Board and Committee Appointments

Invacare adds two new directors after deal with largest investor Azurite

Consensus EPS estimates fall by 77%

Price target decreased to US$4.27

Second quarter 2022 earnings: EPS and revenues miss analyst expectations

Invacare Corporation to Report Q2, 2022 Results on Aug 08, 2022

Invacare Corporation(NYSE:IVC) dropped from Russell 2000 Value Index

Invacare Corporation Introduces the Birdie Evo Xplus Patient Lift to the U.S. Market

Invacare Corporation Introduces the Birdie Evo Xplus Patient Lift to the U.S. Market

Consensus EPS estimates fall by 43%

First quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Invacare Corporation Reaffirms Revenue Guidance for the Full Year 2022

Returns Are Gaining Momentum At Invacare (NYSE:IVC)

Price target decreased to US$6.25

Invacare Corporation to Report Q1, 2022 Results on May 09, 2022

Invacare Corporation, Annual General Meeting, May 19, 2022

Consensus EPS estimates fall by 148%

Price target decreased to US$7.00

Full year 2021 earnings: EPS and revenues miss analyst expectations

Invacare Corporation to Report Q4, 2021 Results on Mar 08, 2022

Invacare Corporation Introduces Its Next Generation E-Fix Eco Power Assist Device to Transform the Manual Wheelchair

Invacare Corporation Introduces New, Narrow Version of Invacare® AVIVA® STORM RX™ Rear Wheel Drive Power Wheelchair

Invacare (NYSE:IVC) Use Of Debt Could Be Considered Risky

Invacare Announces New Features in LiNX® 3 Electronics

Senior VP & GM of EMEA Ralf Ledda has left the company

Returns On Capital Are Showing Encouraging Signs At Invacare (NYSE:IVC)

No longer forecast to breakeven

Third quarter 2021 earnings released: US$0.65 loss per share (vs US$0.21 loss in 3Q 2020)

Here's Why Invacare (NYSE:IVC) Is Weighed Down By Its Debt Load

Price target decreased to US$11.33

Invacare Corporation Provides Sales Guidance for the Third Quarter and Full Year 2021

Independent Director Baiju Shah has left the company

Independent Director recently sold US$59k worth of stock

Consensus forecasts updated

When Should You Buy Invacare Corporation (NYSE:IVC)?

Second quarter 2021 earnings released: US$0.31 loss per share (vs US$0.48 loss in 2Q 2020)

Invacare Corporation Introduces the Invacare® AVIVA STORM RX, a Next Generation Rear Wheel Drive Power Wheelchair

Increases to CEO Compensation Might Be Put On Hold For Now at Invacare Corporation (NYSE:IVC)

Consensus EPS estimates fall to -US$0.56

First quarter 2021 earnings released: US$0.41 loss per share (vs US$0.022 profit in 1Q 2020)

Invacare Corporation Reaffirms Earnings Guidance for the Full Year 2021

Invacare EPS misses by $0.02, misses on revenue

Returns On Capital Are Showing Encouraging Signs At Invacare (NYSE:IVC)

Full year 2020 earnings released: US$0.82 loss per share (vs US$1.59 loss in FY 2019)

Revenue beats expectations, earnings disappoint

Invacare Corporation's (NYSE:IVC) Path To Profitability

Invacare Corporation and Its Subsidiary, Alber Usa, LLC Introduces the Next Generation Alber E-Motion® Power Assist Device